HB 1147, legislation addressing discriminatory acts against entities participating in a 340B drug pricing program, unanimously passed the Senate Health and Human Services Committee and was deemed “certified uncontested” and placed on consent.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.